Published online Aug 11, 2016.
https://doi.org/10.4055/jkoa.2016.51.4.287
Hemodynamic Analysis in Patients Who Underwent Lumbar Spine Fusion Surgery without Blood Transfusion
Abstract
Purpose
Lumbar fusion surgery was performed on transfusion-free patients and hemodynamic changes were analyzed.
Materials and Methods
A total of 36 transfusion-free patients who had undergone lumbar fusion surgery using recombinant human erythropoietin (rHuEPO) before surgery from April 2007 to March 2014 were included in the study. Hemoglobin and hematocrit levels were measured before surgery, immediately after surgery, 12 hours after surgery, on day 1, day 2, day 3, and day 7. Changes in levels were investigated and the factors affecting the changes in hemoglobin levels were analyzed.
Results
Changes in hemoglobin and hematocrit were -18.11% before surgery and -22.92% on day 7, respectively, and they tended to recover from day 2 after surgery. Depending on the patient's age, gender, body mass index, blood loss, and surgery method (presence of lumbar interbody fusion), the changes in hemoglobin level did not show statistically significant differences; however, significant differences were observed in the surgical time and extent of the operation.
Conclusion
Transfusion alternatives during lumbar spinal fusion are deemed safe methods, leading to good, postoperative hemodynamic outcomes. However, the surgical time and extent of the operation must be determined before surgery.
Figure 1
(A) Changes of hemoglobin level following postop. period. (B) Changes of hematocrit level following postop. period. Preop., preoperative; postop., postoperative.
Table 1
Alternative Bloodless Protocol for Preoperation and Postoperation
Table 2
Hemodynamic Changes according to Follow-Up Period from Preop. to Postop. 7 Days
Table 3
Hemodynamic Analysis between Patient's Demographic Factors and Change Rate of the Hemoglobin Level
CONFLICTS OF INTEREST:The authors have nothing to disclose
References
-
Roye DP Jr. Recombinant human erythropoietin and blood management in pediatric spine surgery. Orthopedics 1999;22:s158–s160.
-
-
Lee KY. Spine fusion surgery for the patient refusing allotransfusion. J Korean Soc Spine Surg 2007;14:87–95.
-
-
Goodnough LT, Strasburg D, Riddell J 4th, Verbrugge D, Wish J. Has recombinant human erythropoietin therapy minimized red-cell transfusions in hemodialysis patients? Clin Nephrol 1994;41:303–307.
-
-
Mercuriali F, Inghilleri G. Blood transfusion in oncologic surgery: the role of recombinant human erythropoietin (rHuEPO). Tumori 1998;84:S3–S14.
-
-
Goldberg MA. Perioperative epoetin alfa increases red blood cell mass and reduces exposure to transfusions: results of randomized clinical trials. Semin Hematol 1997;34 3 Suppl 2:41–47.
-
-
Stowell CP, Chandler H, Jové M, Guilfoyle M, Wacholtz MC. An open-label, randomized study to compare the safety and efficacy of perioperative epoetin alfa with preoperative autologous blood donation in total joint arthroplasty. Orthopedics 1999;22:s105–s112.
-
-
Goodnough LT. The safety of recombinant human erythropoietin therapy in autologous blood donors. J Lab Clin Med 1994;124:17–18.
-
-
de Andrade JR, Frei D, Guilfoyle M. Integrated analysis of thrombotic/vascular event occurrence in epoetin alfa-treated patients undergoing major, elective orthopedic surgery. Orthopedics 1999;22:s113–s118.
-
-
Keating M, Faris P, Ritter M. Erythropoietin use. Orthopedics 1998;21:13–14.
-
-
Suh YS, Choi HS, Won SH, Kim MH, Chun DI, Nho JH. Hemodynamic analysis of patients who underwent arthroplasty without blood transfusion. J Korean Orthop Assoc 2010;45:456–463.
-
-
Lisander B, Jonsson R, Nordwall A. Combination of blood-saving methods decreases homologous blood requirements in scoliosis surgery. Anaesth Intensive Care 1996;24:555–558.
-
-
Olsfanger D, Jedeikin R, Metser U, Nusbacher J, Gepstein R. Acute normovolaemic haemodilution and idiopathic scoliosis surgery: effects on homologous blood requirements. Anaesth Intensive Care 1993;21:429–431.
-